Digestion of psychosomatic diseases
Conditions
Interventions
trial group:Eszopiclone alone or combined with Estazolam
control group:Vitamin B complex
Sponsors
Sanming First Hospital affiliated to Fujian Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. The age of patients >= 18 years old and <= 80 years old; 2. Patients with digestive diseases (functional dyspepsia, chronic gastritis, duodenal ulcer, gastric ulcer) whose main manifestations are abdominal pain and who have informed consent to this study. 3. Patients with sleep disorders.
Exclusion criteria
Exclusion criteria: 1. Patients with liver, gallbladder, pancreas, spleen and other primary diseases or space occupying lesions, biliary Ascaris, typhoid and other intestinal and abdominal diseases; 2. Patients with acute onset, such as acute appendicitis, gastrointestinal perforation, intussusception, intestinal obstruction, etc.; 3. Patients with connective tissue diseases, nephropathy, diabetes and its complications or severe organ diseases; 4. Patients with mental disorders; 5. Patients allergic to the study drug; 6. Pregnant or lactating patients; 6. Patients with history of taking sleeping, sedative, anti anxiety and depression drugs within one month before admission.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Upper abdominal pain score;Pittsburgh Sleep index;Polysomnography monitor scores;Determination of inflammatory mediators in serum specimens; | — |
Countries
China
Contacts
Public ContactDu Huang
Sanming First Hospital affiliated to Fujian Medical University
Outcome results
None listed